Scary science: Ondansetron safety in pregnancy-two opposing results from the same danish registry

Gideon Koren

doi:10.1097/FTD.0000000000000020

Scary science: Ondansetron safety in pregnancy-two opposing results from the same danish registry

Gideon Koren

פרסום מחקרי: פרסום בכתב עת › סקירה › ביקורת עמיתים

11 ציטוטים ‏(Scopus)

תקציר

While perceived safe in pregnancy, several recent studies raise concerns about both fetal and maternal safety of ondansetron. Until more data are available, it should not be a first-line medication for morning sickness.

שפה מקורית	אנגלית
עמודים (מ-עד)	1-2
מספר עמודים	2
כתב עת	Therapeutic Drug Monitoring
כרך	36
מספר גיליון	1
מזהי עצם דיגיטלי (DOIs)	https://doi.org/10.1097/FTD.0000000000000020
סטטוס פרסום	פורסם - פבר׳ 2014
פורסם באופן חיצוני	כן

גישה למסמך

10.1097/FTD.0000000000000020

קבצים וקישורים אחרים

Link to publication in Scopus

פורמט ציטוט ביבליוגרפי

@article{1da079e67d2e4a69a5f5a2c016eb1b48,

title = "Scary science: Ondansetron safety in pregnancy-two opposing results from the same danish registry",

abstract = "While perceived safe in pregnancy, several recent studies raise concerns about both fetal and maternal safety of ondansetron. Until more data are available, it should not be a first-line medication for morning sickness.",

author = "Gideon Koren",

year = "2014",

month = feb,

doi = "10.1097/FTD.0000000000000020",

language = "אנגלית",

volume = "36",

pages = "1--2",

journal = "Therapeutic Drug Monitoring",

issn = "0163-4356",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Scary science

T2 - Ondansetron safety in pregnancy-two opposing results from the same danish registry

AU - Koren, Gideon

PY - 2014/2

Y1 - 2014/2

N2 - While perceived safe in pregnancy, several recent studies raise concerns about both fetal and maternal safety of ondansetron. Until more data are available, it should not be a first-line medication for morning sickness.

AB - While perceived safe in pregnancy, several recent studies raise concerns about both fetal and maternal safety of ondansetron. Until more data are available, it should not be a first-line medication for morning sickness.

UR - https://www.scopus.com/pages/publications/84892913741

U2 - 10.1097/FTD.0000000000000020

DO - 10.1097/FTD.0000000000000020

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???

AN - SCOPUS:84892913741

SN - 0163-4356

VL - 36

SP - 1

EP - 2

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

IS - 1

ER -

Scary science: Ondansetron safety in pregnancy-two opposing results from the same danish registry

תקציר

גישה למסמך

קבצים וקישורים אחרים

טביעת אצבע

פורמט ציטוט ביבליוגרפי